Patents matching “chemotherapy”

US 12319738

Anti-FGFR2 antibodies in combination with chemotherapy agents in gastric cancer

Five Prime Therapeutics, Inc. · Granted Jun 3, 2025 · Expires May 29, 2045

US 11786503

Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity

Auransa Inc. · Granted Oct 17, 2023 · Expires Oct 12, 2043

US 11642366

Methods for preventing a serious health consequence and/or tissue damage after exposure to ionizing radiation and/or chemotherapy

GLYCOMIRA THERAPEUTICS, INC. · Granted May 9, 2023 · Expires May 4, 2043

US 11497740

Use of Jumonji C demethylase inhibitors for the treatment and prevention of chemotherapy resistance and radioresistance in cancer

The Board of Regents of the University of Texas System · Granted Nov 15, 2022 · Expires Nov 10, 2042

US 11426385

Methods of improving cancer chemotherapy

THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Aug 30, 2022 · Expires Aug 25, 2042

US 11389432

Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent

Corcept Therapeutics Incorporated · Granted Jul 19, 2022 · Expires Jul 14, 2042

US 11234971

Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent

Corcept Therapeutics Incorporated · Granted Feb 1, 2022 · Expires Jan 27, 2042

US 11166936

Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity

Auransa Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

US 11091555

Method of treating gastric cancer with anti-FGFR2-IIIb antibodies and modified FOLFOX6 chemotherapy

Five Prime Therapeutics, Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

US 10925928

Method for treating chemotherapy-induced male infertility

The Board of Regents of the University of Texas System · Granted Feb 23, 2021 · Expires Feb 18, 2041

US 10874633

Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity

Auransa Inc. · Granted Dec 29, 2020 · Expires Dec 24, 2040

US 10806716

Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity

Auransa Inc. · Granted Oct 20, 2020 · Expires Oct 15, 2040

US 10675271

Clonidine and/or clonidine derivatives for use in the prevention and/or treatment of adverse side effects of chemotherapy

Monopar Therapeutics Inc. · Granted Jun 9, 2020 · Expires Jun 4, 2040

US 10231958

Methods and compositions for enhancing chemotherapy

The Board of Regents of the University of Texas System · Granted Mar 19, 2019 · Expires Mar 14, 2039

US 10195297

Iron garnet nanoparticles for cancer radiotherapy and chemotherapy

The Board of Regents of the University of Texas System · Granted Feb 5, 2019 · Expires Jan 31, 2039

US 9808543

Iron garnet nanoparticles for cancer radiotherapy and chemotherapy

The Board of Regents of the University of Texas System · Granted Nov 7, 2017 · Expires Nov 2, 2037

US 9533025

Method for treating chemotherapy-induced male infertility

The Board of Regents of the University of Texas System · Granted Jan 3, 2017 · Expires Dec 29, 2036

US 9399662

Concurrent chemotherapy and immunotherapy

The Board of Regents of the University of Texas System · Granted Jul 26, 2016 · Expires Jul 21, 2036

US 8546091

AKT phosphorylation at Ser473 as an indicator for taxane-based chemotherapy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 1, 2013 · Expires Sep 26, 2033

US 8480995

Use of sodium selenosulfate for supplementing selenium and enhancing the therapeutic efficacy of chemotherapy agents, and a rapid process for preparing sodium selenosulfate

UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA · Granted Jul 9, 2013 · Expires Jul 4, 2033

US 8481529

Combination cancer chemotherapy

Arizona Board of Regents on Behalf of the University of Arizona · Granted Jul 9, 2013 · Expires Jul 4, 2033

US 8435575

Use of gingerols for cancer patients suffering from nausea and emesis induced by chemotherapy

Aphios Corporation · Granted May 7, 2013 · Expires May 2, 2033

US 8287857

Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 16, 2012 · Expires Oct 11, 2032

US 8147805

Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications

The Board of Regents of the University of Texas System · Granted Apr 3, 2012 · Expires Mar 29, 2032